'Selective modulation of cancer-associated fibroblasts in the tumor microenvironment by the small molecule inhibitor C16' - PhD defence

CRIG member Christophe Mangodt is defending his doctoral thesis entitled 'Selective modulation of cancer-associated fibroblasts in the tumor microenvironment by the small molecule inhibitor C16'.